Amicus Therapeutics | Advancing Therapies to Treat Rare Diseases

A R

re Story

We Believe In Our Future.

A R

re Community

New state of the art research facility builds on the city's 250-year tradition of medical innovation.

A R

re Commitment

Michael, 25 Living with Fabry Disease

We are a biotechnology company at the forefront of advanced therapies to treat a range of devastating rare diseases.

Executive Chairman, John F. Crowley Delivers Notre Dame Commencement Address.

We are leveraging our innovative technology platforms to develop treatments for human genetic diseases.

Be inspired by people living with rare disease across the globe.

Join a team committed to changing the lives of patients with rare metabolic diseases. Now hiring in multiple locations.